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Abstract 45 
Despite the enormous efforts made to achieve effective tools that fight against Staphylococcus 46 
aureus, the results have not been successful. It is likely that such failure is due to the absence 47 
of truly representative experimental models. To overcome this deficiency, the present work 48 
describes and immunologically characterizes the infection for 28 days, in an experimental low-49 
dose (300 CFU) intradermal model of infection in rabbits, which reproduces the characteristic 50 
staphylococcal abscess. Surprisingly, when mutant strains in the genes involved in virulence 51 
(JΔagr, JΔcoaΔvwb, JΔhla and JΔpsma) were inoculated, no strong effect on the severity of 52 
lesions was observed, unlike other models that use high doses of bacteria. The inoculation of a 53 
human “rabbitized” (FdltBr) strain demonstrated its capacity to generate a similar inflammatory 54 
response to a wild-type rabbit strain and, therefore, validated this model for conducting these 55 
experimental studies with human strains. To conclude, this model proved reproducible and may 56 
be an option of choice to check both wild-type and mutant strains of different origins. 57 
 58 
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Introduction 61 
Staphylococcus aureus is a widespread bacterium that has adapted well to humans and animals 62 
which, if provided with a suitable opportunity, can initiate severe infections at various body 63 
sites 1-3. It can cause a wide range of diseases and syndromes, but one of the most worrying 64 
ones, given community-associated infections, are those that affect both skin and soft tissues 4-65 
9. Skin and soft tissue infections (SSTIs) can be minor and self-limiting 1, but if they become 66 
complicated, they can prove life-threatening and be characterized by the formation of large 67 
abscesses 10.  68 
After years of study and millions of dollars invested in research, gaps in our understanding of 69 
S. aureus infections remain, and it is not known in detail how staphylococcal infections evolve 70 
in humans. Numerous studies have been conducted on the pathogenesis of this bacterium 1, 71 
usually for the ultimate objective of developing therapeutic tools against staphylococcocal 72 
infections 11. However, practical results remain frustrating because even today there are no 73 
effective preventive therapies, but resistance to antibiotics is growing and has reached really 74 
worrying levels. The	problem	could	lie	in	the	fact	that	the	results	experimentally	obtained	75 
in	inadequate	animal	models	have	been	assumed	and	almost	never	questioned.  76 
There are two important aspects to be taken into account in experimental staphylococcal 77 
infections: the animal species and the strain used. The murine has been the most frequently 78 
studied animal model. However, unlike humans, mice are not natural hosts for S. aureus. 79 
Conversely, rabbits (the second most frequently used animal species) usually suffer natural 80 
infections by S. aureus. In fact, numerous strains have been reported in commercial rabbitries 81 
12 ever since a sporadic mutation favored the human-to-rabbit host jump 40 years ago 13. It has 82 
been described that human skin morphological 14,15 and immunological 16 characteristics are 83 
more similar to those of rabbit than to those of mice. For this reason, the skin rabbit model is 84 
 
more appropriate than the murine one if the objective is to simulate S. aureus infection in 85 
humans. 86 
In order to develop experimental infections using human S. aureus strains in mice, and even in 87 
rabbits 17, the inoculation of an extraordinary large number of bacteria is necessary as they are 88 
strains that have not adapted to these hosts, which places at a distance the results obtained in 89 
the laboratory from what actually occurs under natural conditions. So in these cases, animal 90 
models can be unreliable predictors of either the potential success of therapeutic or preventive 91 
interventions or the roles played by specific determinants of bacterial virulence in infection 2. 92 
This is why it is necessary to develop better animal models of colonization that are more 93 
representative of what happens in in vivo situations 3.  94 
In this article we present, for the first time, a detailed description of staphylococcal dermal 95 
infection in a rabbit model at low doses to mimic natural infection and to approach what should 96 
occur in natural infections in humans in the most realistic way possible. The specific objectives 97 
of this study are to: (1) describe and characterize a low-dose rabbit S. aureus intradermal 98 
infection model using a wild-type reference strain and several mutant strains in different key 99 
pathogenicity factors that somehow contribute in abscess formation; (2) confirm the utility of 100 
this model after infection with a human adapted-to-rabbit (“rabbitized”) S. aureus strain and 101 
compare their response with different rabbit strains of known virulence. 102 
 103 
  104 
 
Materials and Methods 105 
General approach 106 
This study was designed in two phases: the first intended to (1a) establish a detailed description 107 
of the evolution of lesions and the immune response after infection with low doses of a wild-108 
type S. aureus rabbit strain and (1b) study the effect of different genes on the pathogenesis of 109 
intradermal staphylococcal infections. The second intended to (2) prove the reproducibility of 110 
this experimental model with a human “rabbitized” strain. 111 
 112 
Bacterial strains and growth conditions 113 
The S. aureus strains used in this study were: Jwt (a rabbit ST121 wild-type strain isolated from 114 
a natural case of staphylococcosis) and deletion strains isogenic coa/vwb (JΔcoaΔvwb), hla 115 
(JΔhla), psmα (JΔpsmα) and agr (JΔagr); Jrot+ (Jwt with rot gen restored); JdltBh (Jwt with the 116 
reversion of three identified dltB Single Nucleotide Polymorphism –SNPS-); and FdltBr, a 117 
human ST121 strain expressing dltB from rabbit clones 13 (Table 1). 118 
Bacteria were grown at 37°C overnight on TSA agar medium supplemented with antibiotics as 119 
appropriate. Broth cultures were grown at 37°C in TSB broth with shaking (240 r.p.m.). The 120 
procedures for the preparation and analysis of phage lysates, transduction and transformation 121 
in S. aureus were performed essentially as previously described 20 21. 122 
 123 
DNA methods 124 
General DNA manipulations were performed by following standard procedures 22. 125 
To produce the mutant strains, plasmid pMAD was used 23, as previously described 24. The 126 
oligonucleotides used herein are listed in Table 2. Briefly, two separate PCR products with 127 
overlapping sequences, including the targeted sequence, were combined. A second PCR was 128 
run with external primers to obtain a single fragment. Specifically, 1 mL of each of the first 129 
 
PCRs was mixed with 10 pM of the outside primers and was PCR-amplified. The fusion 130 
products were purified and cloned at the appropriate sites of shuttle plasmid pMAD, and the 131 
resulting plasmids were transformed into S. aureus (RN4220) by electroporation 20. pMAD 132 
contains a temperature-sensitive origin of replication and an erythromycin-resistance gene. The 133 
plasmid was integrated into the chromosome through homologous recombination at a non-134 
permissive temperature (43.5°C). From the 43.5°C plate, one to five colonies were picked into 135 
10 mL of TSB and incubated for 24 h at 30°C. Ten-fold serial dilutions of this culture in sterile 136 
TSB were plated on TSA containing X-gal (5-bromo-4-chloro-3-indolyl-B-D-137 
galactopyranoside; 150 mg/mL). White colonies, which no longer contained the pMAD 138 
plasmid, were tested to confirm replacement by DNA sequencing. Primers were obtained from 139 
Invitrogen Life Technologies (Paisley, UK). 140 
 141 
Animals and sampling times  142 
Two hundred and twenty 2-month-old albino hybrid rabbits (Oryctolagus cuniculus) (10 143 
animals per sampling time) of either gender were inoculated with the eight above-described S. 144 
aureus strains. Depending on the inoculated strain, samples were taken at different times (Table 145 
1). After a detailed study of lesions induced by the Jwt strain on different days postinfection 146 
(dpi) (0, 0.5, 1, 2, 3, 7, 14, 21, 28), it was established that 7 dpi was the optimal time to compare 147 
infections with mutants in various toxins (JΔcoaΔvwb, JΔhla, JΔpsmα) and general regulators 148 
(JΔagr) as it was the time of maximum lesion development (abscesses opening and emptying) 149 
and when repair phenomena commenced. Then 1, 3 and 7 dpi were selected to compare the 150 
behavior of a human “rabbitized” strain (FdltBr) with three rabbit strains (Jwt, Jrot+, JdltBh) of 151 
well-known virulence in the acute and early chronic phases of infection evolution because, as 152 
before (7dpi), some important milestones were observed: on 1 dpi, externally evident lesions 153 
 
(papules) and the formation of initial abscesses and on 3 dpi, skin necrosis, multiple Splendore-154 
Hoeppli phenomena and an eosinophilic layer surrounding abscesses.  155 
Animals were housed under conventional environmental conditions with an alternating cycle 156 
of 16 h of light and 8 h of darkness in individual cages (600 x 750 x 600 mm) and were fed 157 
with a commercial rabbit diet ad libitum.  158 
The experimental protocol was approved by the Ethical Committee of the Universidad CEU 159 
Cardenal Herrera and by the Conselleria d’Agricultura, Pesca i Alimentació, Generalitat 160 
Valenciana (permit numbers 2011/010 and 2017/VSC/PEA/00192; date of approval: January 161 
20, 2011). All the animals were handled according to the principles of animal care published 162 
by Spanish Royal Decree 1201/2005 (BOE, 2005). 163 
 164 
Intradermal infection model  165 
The experimental procedure was performed as previously described 25, with some 166 
modifications. Briefly, rabbits were intradermally-inoculated in their backs with 300 colony 167 
forming units (CFU) of each studied strain suspended in 0.1 mL of phosphate-buffered saline 168 
(PBS) to inoculate animals with the lowest infective doses of bacteria. The optimal number of 169 
bacteria in the inoculum was empirically determined in the preliminary experiments. 170 
Previously, animals were sedated with a combination of ketamine (Imalgene®, 100 mg/mL, 171 
Merial, Barcelona, Spain) and xylazine (Xilagesic, 200 mg/mL, Calier, Barcelona, Spain) and 172 
a 10x10 cm area of the dorsal-lumbar region was shaved and disinfected with chlorhexidine. 173 
To avoid interactions among strains, each rabbit was infected with only one strain (except in 174 
the phase 1b where Jwt was inoculated as control), which were inoculated in duplicate. The 175 
general status, weight and rectal temperature of animals were recorded daily. 176 
 177 
 
Gross, microscopical and microbiological studies 178 
The characteristics of the skin gross lesions (presence of erythema, edema, skin elevation, 179 
nodules, dermo-necrosis and/or ulceration) were recorded daily. Abscess dimensions were 180 
measured with a calliper. The length (L) and width (W) values were used to calculate abscess 181 
areas (A = π [L x W]/2) and volumes (V = 4/3π[L/2]2 x [W/2]) 26,27. Macroscopic lesions were 182 
evaluated by their abscess area as follows: Healthy (no apparent lesions), Mild (< 0.5 cm2), 183 
Moderate (0.5-5 cm2) or Severe (>0.5 cm2 and gross necrosis). 184 
Upon sampling, rabbits were sedated with a combination of ketamine (Imalgene®, 100 mg/mL) 185 
and xylazine (Xilagesic, 200 mg/mL), and were euthanized by an intravenous injection of 186 
barbiturate (T-61, Intervet International GmbH, Unterschleißheim, Germany) and a complete 187 
necropsy was carried out. Skin samples from the inoculation place were used for the 188 
microscopic and microbiological studies and the cytokine assay. For the histological 189 
examination, skin samples were routinely stained with hematoxylin and eosin (H&E), Masson’s 190 
trichrome and Gram’s stains, and were processed by immunohistochemistry for macrophages, 191 
T- and B-lymphocytes and plasma cell detection by the avidin-biotin-peroxidase complex 192 
method at the dilutions recommended by the manufacturer (Table 3). In the 193 
immunohistochemical procedure, positive cells were enumerated in the inoculation areas and, 194 
when lesions were very severe, in the border of the necrotized tissue of twenty 0.08 mm2 195 
randomly selected fields per slide. The histological and immunohistochemical findings 196 
observed on the different skin layers were described and recorded in detail.  197 
Prior to fixation, representative samples were taken from skin lesions and kidneys, and were 198 
weighed under sterile conditions for the microbiological studies. Then they were immersed in 199 
a cold solution of PBS and mechanically homogenized in the presence of ice. One hundred µL 200 
of tissue homogenate were cultivated on blood-agar (BioMérieux, Marcy l’Etoile, France) and 201 
were incubated aerobically at 37°C for 24 h. This allows the results to be expressed in CFU/g. 202 
 
The colonies that grew were identified by coagulase PCR 12 to prove that the strains isolated 203 
from skin lesions were the same as those originally inoculated and to assess the possibility of 204 
septicemia in the samples taken from kidneys.  205 
 206 
Hematology and flow cytometric analyses 207 
Blood samples (1 mL) in EDTA anticoagulant were obtained from the median artery of the ear. 208 
White blood cell (WBC) counts and lymphocyte proportions were determined using a 209 
hematology analyzer (MEK-6410, Nihon Kohden, Tokyo, Japan). The flow cytometric analysis 210 
of the white blood cells (B, T, T CD4+, T CD8+ and activated T-cells, monocytes and 211 
granulocytes) was performed using specific primary antibodies (Table 4) and secondary 212 
antibodies (rat anti-mouse IgG2a+b phycoerythrin conjugate, VMRD; goat anti-mouse IgM 213 
phycoerythrin conjugate, AbD Serotec, Kidlington, UK), as previously described 28,29. 214 
The common leukocyte antigen CD14 and CD45 expression was used for the “lymphogate” 215 
setup, as previously described 28,29. The calculation of the total lymphocyte and the respective 216 
subset counts were performed as the product of the WBC count and specific population 217 
percentages, as described elsewhere 29,30. 218 
 219 
Cytokine assay 220 
The representative interleukins of the immune response (IL-1β, IL-4, IL-17, IL-18 and IFN-221 
gamma) from plasma and the inoculated skin tissues were analyzed by ELISA kits (CUSABIO, 222 
Wuhan, Hubei Province, P.R. China) according to the manufacturer’s protocol. Previously, the 223 
samples taken from skin abscesses were immersed in a cold solution of PBS with a protease 224 
inhibitor (Complete Mini, Roche, Basel, Switzerland), and were mechanically homogenized for 225 
a 1 min by stopping each 10 s to avoid overheating in a T50 Ultra-Turrax ® (IKA, Staufen, 226 
 
Germany) in the presence of ice. Next they were centrifuged at 13000 g for 10 min. Aliquots 227 
of the supernatant were stored at -80°C for further processing. 228 
 229 
Statistical analysis 230 
Study 1a. Characterization of the model after infection with Jwt. 231 
The data obtained in this study were evaluated by five different models depending on the type 232 
of data recorded for each trait (Tables 1 and Supplemental Table 1). The five models included 233 
the postinoculation day (9 levels: 0; 0.5; 1; 2; 3; 7; 14; 21; 28) as the fixed effect. Except for 234 
CFU, the data of quantitative traits with one record per animal were analyzed by a linear model 235 
M1 (proc GLM, SAS, 9.2). CFU usually presents changes in the order of magnitude as 236 
infections evolve. In order to take this situation into account, the CFU data were analyzed by a 237 
mixed model M2 and by considering different variances for the random residual errors on each 238 
postinoculation day. The data of the quantitative traits with more than one record per animal 239 
were analyzed by a mixed model M3 (proc MIXED, SAS, 9.2), which included the effect of 240 
the individual upon infection as random effects [90 levels; N~ (0, sp)]. The data of the 241 
categorical traits with two levels (e.g.: yes/no, presence/absence, 0/1, etc.) were analyzed by a 242 
generalized linear model M4 (proc GENMOD, SAS, 9.2) after considering that the response 243 
variable followed a binomial distribution and by using logistic transformation [ln (µ / (1-µ))] 244 
as a link function. Finally, the ordinal data of the histology traits had more than two levels 245 
because injuries were classified according to a previously described scale (-, - / +, +, + / ++, ++, 246 
++ / +++, +++, +++ / ++++, ++++), where ++ was greater (severer) than +. However, this did 247 
not mean that the distance between each class was proportional. To take this situation into 248 
account, the data of the histology traits were analyzed by a generalized linear model M5 (proc 249 
GENMOD, SAS, 9.2) after considering that the response variable followed a multinomial 250 
probability distribution and that the link function followed a cumulative logistic distribution 31.  251 
 
Study 1b. Effects of the selected genes and the global regulator involved in abscess 252 
development. 253 
A pair-wise comparison of the means was performed using Yates correction. The t-student test 254 
was performed for the traits with quantitative data and the chi-square test for the traits with 255 
categorical data [M6]. 256 
Study 2. Comparison of the lesions caused by a human “rabbitized” strain and different rabbit 257 
strains of known virulence. 258 
The data obtained in this study were evaluated by four different models depending on the type 259 
of data recorded per trait (Supplemental Table 1). The four models included day 260 
postinoculation (3 levels; 1, 3, 7), the strain (4 levels: Jwt, FdltBr, Jrot+, JdltBh) and their 261 
interaction as fixed effects. Except for CFU, the data of the quantitative traits with only one 262 
record per animal were analyzed by a linear model M7 (proc GLM, SAS, 9.2). CFU was 263 
analyzed by a mixed model M8 after considering the different variances for the random residual 264 
errors on each day postinoculation. The data of the quantitative traits with more than one record 265 
per individual were analyzed by a mixed model M9 (proc MIXED, SAS, 9.2) and included the 266 
effect of the individual at the experimental infection time as random effects [120 levels; N~ (0, 267 
sp)]. Finally, the data of the ordinal categorical traits with more than two levels (histology 268 
variables) were analyzed by a generalized linear model M10 (proc GENMOD, SAS, 9.2) after 269 
considering that the response variable followed a multinomial probability distribution and that 270 
the link function followed a logistic distribution cumulative 31. 271 
 272 
 273 
  274 
 
Results 275 
Study 1a. Characterization of the model after infection with a rabbit wild-type strain (Jwt): 276 
infection with low doses of bacteria generates a characteristic and identifiable pathological 277 
response over time 278 
After evidencing that rabbits can be infected by a low-dose charge of S. aureus 13, we set out to 279 
make a detailed description, for the first time, of the pathogenesis of staphylococcal infections 280 
in the model that best mimicked staphylococcal disease in humans: the rabbit experimental 281 
model. 282 
 283 
Health parameters  284 
A slight stagnation of animals’ weight on the first 3 days after infection was detected, but they 285 
grew normally during the rest of the experiment. Although an increase in rectal temperature 286 
was observed during the study (38.5 at 0dpi and 39.5 at 28dpi; P=0.001), fever was not detected 287 
in any animal and the temperature values fell within physiological ranges. 288 
 289 
Gross lesions 290 
Lesions of different severities developed in all cases after the inoculation of 300 CFU of S. 291 
aureus (Fig. 1A). Small (< 1 cm in diameter), flat and circumscribed red macules were observed 292 
at the point of inoculation at 0.5 dpi in 100% of the animals. These lesions evolved to slightly 293 
elevated papules (1dpi) and firm nodules (2dpi) in the 100% of the animals and at 100% of the 294 
inoculation points (20 out of 20). The size and intensity of the reddened areas reached its apogee 295 
at 2 dpi (2.003±0.51 vs. 3.422±0.47 cm2 on 1 and 2 dpi, respectively; P<0.001) and gradually 296 
disappeared after 3 dpi. At this time (3 dpi), the volume of nodules was maximum (4.561±1.15 297 
cm3; P<0.001) and 50% of the animals (5 out of 10) at 7 dpi showed epidermal necrosis in the 298 
inoculation zone characterized by darkness, and suppurative to dry (parchment) areas that 299 
 
opened between 7 and 14 dpi in all cases to result in ulceration and discharged a purulent 300 
material. Draining abscesses reduced abscess size. From 14 dpi to 28 dpi, a repair of the ulcers 301 
occurred, and absence of hair and scar retraction were observed at the end of the study (Fig. 2).  302 
 303 
Bacteriology 304 
The bacterial counts increased at 0.5 dpi (1.11 x 107 CFU/g), with the largest number obtained 305 
at 3dpi (50.98 x 107 CFU/g) and, coinciding with the opening of abscesses, the number of 306 
bacteria lowered until the end of the experiment, when the lesions of only four of ten animals 307 
contained bacteria (1.16 x 103 CFU/g at 28dpi) (Fig. 3). All the cultured and identified bacteria 308 
recovered from lesions were the same as those inoculated and no bacteria were isolated from 309 
blood or kidneys. 310 
 311 
Histological findings  312 
Some animals showed early histopathological modifications at 0.5 dpi (Table 5). In these cases, 313 
lesions were characterized by moderate edema and minor hemorrhages in the superficial dermis 314 
and a by slight increase in the density of heterophils in the deep dermis, which sometimes 315 
grouped into small clusters of cells (Figs. 1B and 4A). The capillary surrounding these 316 
inflammatory foci were hyperemic. The capillaries located near or between cutaneous muscle 317 
cells were also dilated and hyperemic, with the presence of heterophils migrating by diapedesis 318 
to the interstice. Small hemorrhagic foci between adipocytes near the cutaneous muscle were 319 
detected. 320 
Vascular phenomena, such as hyperemia (vascular dilatation and presence of numerous 321 
intravascular heterophils), mild to moderate edema and hemorrhages were detected in the 322 
superficial dermis on 1 dpi. The deep dermis showed hyperemia and numerous heterophils 323 
around dilated blood vessels and inflammatory foci structured as a core of eosinophilic necrosis, 324 
 
sometimes with coccoid bacteria surrounded by diffusely distributed heterophils (Fig. 4B). 325 
Cutaneous muscle fibers were infiltrated by heterophils, which provoked a mild degeneration 326 
and atrophy of myocytes (Fig. 1C). 327 
Two days after infection, lesions were similar to the way there were the previous day, but 328 
presented greater severity. It was the first time that clear epidermis thickening (moderate 329 
acanthosis) was detected (10% of animals). The presence of mild vascular dilatation, moderate 330 
edema and some hemorrhages in the superficial dermis was observed. In the deep dermis, 331 
inflammatory foci were better well-defined than they were previously. They were characterized 332 
by a center of eosinophilic necrosis, inside which there were coccoid bacteria surrounded by a 333 
dense layer of heterophils (Fig. 4C). Around these foci there were also heterophils. Cutaneous 334 
muscle cells were severely infiltrated by heterophils, which induced their separation and 335 
necrosis (Figs. 1D and 4D). 336 
On 3 dpi, the percentage of animals with moderate to severe epidermal hyperplasia was higher 337 
than on 2 dpi (46% vs. 10%). The presence of more severe vascular phenomena (vascular 338 
dilatation, edema and hemorrhages) in the superficial dermis induced skin tumefaction, and also 339 
epidermis necrosis when the volume of abscesses was sizeable (Fig. 4E). In the deep dermis, 340 
the severity of edemas and hyperemia diminished. The latter was observed only around 341 
suppurative foci, together with diapedesis phenomena of heterophils. Inflammatory foci were 342 
structured by a center with bacterial colonies surrounded by a star-shaped homogeneous 343 
eosinophilic material (Splendore-Hoeppli phenomenon) and an external layer of cellular debris 344 
and inflammatory cells (mainly lymphocytes, macrophages and heterophils) (Fig. 4F). When 345 
abscesses were large, this pattern was repeated and they merged with one another to form the 346 
abscess. Externally, abscesses were partially or totally surrounded by a thin eosinophilic layer 347 
of necrosis (Fig. 4G). The myocytes of cutaneous muscle were infiltrated by eosinophils and 348 
macrophages, and showed dilatation, degeneration and, sometimes, atrophy (Figs. 1E and 4H).  349 
 
The main characteristic on 7 dpi was the presence of local epithelial necrosis and epidermis 350 
ulceration with severe acanthosis in the peripheric epithelium (Fig. 4I), together with severe 351 
hyperemia, edema and hemorrhages in the superficial dermis. At greater depths, abscesses 352 
showed several Splendore-Hoeppli phenomena, whose peripheral inflammatory reactions 353 
merged with one another. An external thin eosinophilic layer surrounded abscesses. Around 354 
abscesses, heterophils diffusely distributed or a few were seen and some of the capillary vessels 355 
were reactive (presence of endothelial hyperplasia and hypertrophy). The cutaneous muscle was 356 
interrupted by an inflammatory infiltrate (heterophils and round cells) that caused the atrophy 357 
of the affected cells (Fig. 1F).  358 
On 14 dpi, the severity of some inflammatory phenomena started to decrease and repair 359 
appeared more evident (Fig. 1G). In those cases in which the epithelium was lost, epidermis 360 
re-epithelization, characterized by the presence of numerous mitotic figures on the basal and 361 
spinosum layers at the borders of the ulcer, was observed (Fig. 4J) together with the absence 362 
of skin adnexa (sweat and sebaceous glands and hair follicles). All the animals showed 363 
acanthosis. The vascular phenomena were milder, but still evident in the superficial dermis like 364 
inflammatory foci with bacteria and, in some cases, Splendore-Hoeppli phenomena, all 365 
surrounded by an eosinophilic layer in the deep dermis. In adjacent areas, granulation tissue 366 
(numerous small vessels and abundant fibrous tissue) was observed (Fig. 4K). On the muscular 367 
layer, focal fibrosis and atrophy of some cells were observed. Other locations presented 368 
hypertrophy and hyperplasia of muscular fibers.  369 
On 21 dpi, mitotic cells and hyperplasia in the peripheral epithelium of lesions were observed, 370 
even in those few rabbits that still had ulcers in the epithelium. When lesions were completely 371 
epithelized, the epidermis was 2-3-fold thicker than in the unaffected areas (Fig. 5). In the 372 
dermis (mainly in the deep dermis), abundant granulation tissue was observed with numerous 373 
small blood vessels and heterophils forming small cellular aggregates or diffusely distributed, 374 
 
mainly near cutaneous muscle which, in some cases, was still interrupted by inflammatory cells 375 
and atrophied (Fig. 1H). 376 
Finally, on 28 dpi, the epidermis of all the animals showed hyperplasia, but with a thinner 377 
epithelium than on 21 dpi (1.5-fold thicker than normal). Skin adnexa were absent in the central 378 
lesion, but the periphery was invaded by hair follicles as a consequence of scar retraction (Fig. 379 
1I). The dermis presented mature granulation tissue with abundant fibrous tissue and blood 380 
vessels, practically without erythrocytes and with scarce heterophils, as well as some small 381 
hemorrhages (Fig. 4L). Cutaneous muscle had completely regenerated.  382 
 383 
Immunohistochemical studies 384 
Variations in the counts of the studied cells (T-lymphocytes CD3+, plasma cells IgG+ and 385 
macrophages RAM11+) were detected locally in the inoculation area during the experiment. 386 
The T-lymphocytes (CD3+) counts increased during the experiment until 21 dpi (17.55±1.90 387 
cells/mm2) and then abruptly dropped on 28 dpi (Fig. 6A). Plasma cells (IgG+) appeared in 388 
small groups, mainly in the deep dermis. They were few in number in lesions in the acute 389 
inflammation phase (first 3 days), but significantly increased on 7 dpi and remained high on 14 390 
and 21 dpi (11.03, 11.78 and 11.15±1.93 cells/mm2, respectively; P<0.001), and once again 391 
abruptly decreased on 28 dpi (Fig. 6B). The macrophages counts (RAM11+) remained with no 392 
differences compared to 0 dpi until 3 dpi when they significantly increased until 14 dpi. At this 393 
time, the number of macrophages reached the highest level (10.75±1.16 cells/mm2; P<0.001) 394 
before lowering on 21 dpi (still higher than on 0 dpi) and 28 dpi (Fig. 6C). Macrophages were 395 
diffusely located in the inoculation area when no abscess was present, but when abscesses 396 
started organizing, macrophages were located around them and formed a palisade on the outer 397 




Flow cytometer results 401 
Figure 5 shows the results of the flow cytometric analysis done of the peripheral blood cells in 402 
the rabbits infected by S. aureus Jwt. Intradermal inoculation induced modifications in the 403 
counts of most leukocyte populations (granulocytes, monocytes and total B and T CD25+ 404 
lymphocytes). Total leukocytes (Fig. 6D) and granulocytes (Fig. 6F) counts showed two peaks 405 
during the study: a first sharp increase on 1 dpi and a second greater increase from 7 to 14 dpi, 406 
which decreased on 21 dpi (more abruptly for granulocytes). The number of monocytes (Fig. 407 
6G) gradually increased from 3 to 14 dpi, when its highest value was reached (869.5 x 106/L; 408 
P <0.001). The number of total lymphocytes rose from 0 to 2 dpi, when counts were kept 409 
elevated until the end of the experiment (Fig. 6E). Regarding the lymphocyte subpopulations, 410 
statistical differences were observed only in the B (Fig. 6H) and CD25+ (Fig. 6I) lymphocytes. 411 
B-cells had higher values at 0.5, and especially at 21 dpi, compared to 0 dpi (43.29 and 81.66 412 
x 106/L, respectively; P<0.001). The cell counts of the CD25+ lymphocytes abruptly increased 413 
on 0.5 dpi and were 11.9-fold higher than on 0 dpi and on later experimental days. No 414 
significant differences were observed in the number of T-lymphocytes, T CD4+ lymphocytes 415 
and T CD8+ lymphocytes. 416 
 417 
Plasmatic and tissue cytokines 418 
Statistical differences were detected only in IL-4 and IL-18 in plasma and in IL-4 and IFN-419 
gamma in skin samples (Table 6). The plasmatic levels of IL-4 and IL-18 oscillated throughout 420 
the experiment. Relative to 0 dpi, statistical differences were only detected for IL-4 on 28 dpi 421 
and IL-18 on 14 and 28 dpi, where these cytokines reached their highest plasmatic levels (8.9 422 
pg IL-4/mL and 463.4 pg IL-18/mL) on 28 dpi. Similarly to plasma, the IL-4 detected in skin 423 
tissue significantly increased on 28 dpi (15.5 pg/mL; P<0.05). Conversely, the IFN-gamma 424 
 
level in tissues abruptly increased on 0.5 dpi (14015±1804 pg/ml; P<0.05) before returning to 425 
previous levels. No significant differences were observed in IL-1β and IL-17 levels. 426 
 427 
 428 
Study 1b. Effects of the selected genes and the global regulator involved in abscess 429 
development: mutants in different key genes for abscess development cause a delay in 430 
lesions, but are still able to infect animals and generate abscesses  431 
Once the lesions and peripheral and local immune responses had been described, the aim of this 432 
section was to evaluate the contribution of different isogenic mutants of the Jwt strain (JΔagr, 433 
JΔcoaΔvwb, JΔhla and JΔpsma) to the development and characteristics of abscesses on 7 dpi 434 
using the proposed rabbit skin model. Unexpectedly, all the mutant strains were able to generate 435 
lesions like the wild-type in terms degree of severity (Fig. 7). Whenever present, lesions were 436 
macroscopically indistinguishable from those generated by the wild-type strain.  437 
At the histological level, Splendore-Hoeppli phenomena were observed with all the strains, but 438 
not with the same incidence. Only statistically differences were observed with JΔhla (85% Jwt 439 
vs. 68% JΔhla; P<0.05) (Fig. 8A). The percentage of distributed heterophiles surrounding the 440 
abscesses was higher in the mutant strains with respect to Jwt (+20% for JΔcoaΔvwb, +50% 441 
for JΔhla and +30% for JΔpsma and JΔagr; P<0.05) (Fig. 8B). All the lesions caused by each 442 
studied strain (the wild-type and mutants) presented an eosinophilic layer surrounding 443 
abscesses on 7 dpi. However, there were differences in the characteristics of this band. The 444 
percentage of complete eosinophilic layers always was lower for mutants than for Jwt (-30% 445 
for JΔcoaΔvwb, -90% for JΔhla, -45% for JΔpsma and -50% for JΔagr; P<0.05) (Fig. 8C). 446 
These histological differences are related to the degree of maturation of the abscess. Thus, the 447 
lesions generated by the mutants at 7 dpi resembled those presented by the wild-type strain in 448 
 




Study 2. Comparison of the lesions caused by a human “rabbitized” strain and different 453 
rabbit strains of known virulence: similar, but milder lesions to the rabbit wild-type strain 454 
are caused by a human rabbitized strain after intradermal inoculation 455 
Once the infection model had been characterized and that all the rabbit strains were capable of 456 
generating lesions at low doses had been verified, our intention was to test the model with a 457 
human strain. The inconvenience here is that human S. aureus strains (e.g., F strain) do not 458 
cause lesions at low doses (300 CFU) in rabbits 13. In fact to be able to produce them, it is 459 
necessary to use high bacterial doses (more than 104 CFU) and, when this occurs, the evolution 460 
of lesions (faster) and the produced characteristics (e.g. presence of extensive coagulative 461 
necrosis, thrombosis, absence of Splendore-Hoeppli phenomena or peripheral eosinophilic 462 
layers on 3 dpi) differ vastly from those observed by rabbit strains at low doses (JM Corpa, 463 
personal communication, Supplemental Figure 1). Therefore, we had to use a human strain 464 
adapted to rabbits (FdltBr), which we had previously demonstrated was able to infect this 465 
species at low doses 13. 466 
The specific aim was to compare the response to infection after inoculating the FdltBr strain 467 
with S. aureus strains obtained from rabbits of known virulence, such as Jwt (high virulence), 468 
Jrot+ (medium virulence) and JdltBh (low virulence), using the previously described model to 469 
demonstrate its utility with strains of different origins. 470 
 471 
  472 
 
Health parameters  473 
No animal suffered fever and no differences in temperature between the studied groups were 474 
observed.  475 
 476 
Gross lesions 477 
Differences in both the number of infected animals and the characteristics of their lesions after 478 
inoculation with the studied S. aureus strains were detected. While 100% of the rabbits were 479 
infected by human FdltBr and rabbit Jwt, 76.7% and 60% of the animals inoculated with Jrot+ 480 
and JdltBh showed lesions, respectively. The severity of lesions caused by FdltBr was 481 
intermediate, between Jwt (severer lesions) and Jrot+ and JdltBh (milder lesions) (Fig. 9).  482 
On 1 dpi, the inoculation points showed erythema in 100% of the animals infected by FdltBr, 483 
Jwt and Jrot+ and 80% in the rabbits inoculated with FdltBr. On 3 dpi, lesions evolved to nodules 484 
in 100% of the animals infected by the FdltBr and Jwt strains, but only in 30% of the rabbits 485 
inoculated with Jrot+, and 10% with JdltBh. At the end of the experiment (7 dpi), while all the 486 
animals infected with FdltBr and Jwt presented nodules, even some developed dermonecrosis 487 
(10% and 50%, respectively), only 50% of the rabbits inoculated with Jrot+ and JdltBh showed 488 
lesions. The animals infected with Jrot+ exhibited erythema and nodules (40%), but erythema 489 
was observed only in the rabbits infected with JdltBh at this time point.  490 
 491 
Bacteriology 492 
The bacterial counts obtained from the animals inoculated with FdltBr and Jrot+ followed the 493 
same dynamics as the Jwt strain on 1, 3 and 7 dpi (Fig. 10), but the average number of bacteria 494 
obtained from their lesions was smaller (6.18±32.21 x 106 and 1.10±47.54 x 106 CFU/g, 495 
respectively, P<0.05) than from the lesions caused by Jwt (244.36±36.98 x 106 CFU/g). 496 
Bacteria were isolated only in one animal infected by JdltBh on 3 dpi (2.26 x 103 CFU/g) at 497 
 
3dpi. All the cultured and identified bacteria recovered from lesions were the same as those 498 
inoculated, and no bacteria were isolated from blood or kidneys. 499 
 500 
Histological findings  501 
Different degrees of severity were observed in the histological lesions depending on the type of 502 
inoculated strain (Table 7). In general, FdltBr caused more similar (but milder) lesions to the 503 
Jwt strain than to the other two. Vascular dilatation and edema in the superficial dermis 504 
observed in the animals infected by FdltBr were severer than Jrot+ and resembled Jwt.  505 
The abscesses caused by FdltBr were evident on 1 dpi and were more numerous and severer on 506 
3 dpi, similarly to Jwt. Conversely, the severity of the abscesses (heterophils organized, Table 507 
7) in the animals infected by Jrot+ and JdltBh reduced on 3 dpi. In this last case, abscesses were 508 
classified mainly as “mild” (Fig. 11A).  509 
The abscesses produced by the three mutant strains were histologically more immature 510 
compared to Jwt as they did not show a complete eosinophilic peri-abscess layer. On 3 dpi, all 511 
the Jwt-related abscesses had a well-developed eosinophilic layer, only 55% of FdltBr and 20% 512 
of Jrot+ had one, and no band was detected in the JdltBh abscesses. At the end of the experiment 513 
(7 dpi), percentages varied, but differences remained (100% Jwt; 36% FdltBr; 30% Jrot+ and 514 
0% JdltBh). 515 
It was noteworthy that Splendore-Hoeppli phenomena were seen only in the abscesses from the 516 
rabbits infected by Jwt and Jrot+ on 3 and 7 dpi. There were fewer Splendore-Hoeppli 517 
phenomena in Jrot+ (1 on 3 dpi and 2 on 7 dpi) than in Jwt (5 on 3 dpi and 8 on 7 dpi), although 518 
the number of abscesses also lowered with Jrot+ (2 on 3 dpi and 3 on 7 dpi) than with Jwt (10 519 
at both time points). 520 
 
The degree of dilated blood vessels in the deeper dermis close to cutaneous muscle was higher 521 
in the animals inoculated with strains FdltBr and JdltBh for all the studied times, but the 522 
incidence of perivascular inflammation was higher with Jwt (P<0.05) (Table 7).  523 
The pathological findings (inflammation and degeneration) observed in cutaneous muscle were 524 
similar between strains FdltBr and Jwt, and were severer than those caused by strains Jrot+ and 525 
JdltBh (P<0.05) (Table 7).  526 
 527 
Immunohistochemical studies 528 
The number of positive cells was related to lesion severity, with no positive cells in the animals 529 
without lesions regardless of the inoculated strain. The number of studied cells in the lesions 530 
caused by FdltBr strain infection was lower to those of the wild-type strain (Jwt) and more 531 
similar to those of strain Jrot+ and JdltBh (Fig. 11B-E). The T-lymphocytes (CD3+) counts were 532 
significantly higher during the three moments analyzed in the Jwt compared to FdltBr. The 533 
macrophages counts (RAM11+) were significantly higher on 3 and 7 dpi in the animals infected 534 
with Jwt regarding to FdltBr, and the counts of B-lymphocytes (CD79α+) and plasma cells 535 
(IgG+) were significantly higher on 3 and 7 dpi, respectively. The lesions produced by the 536 
inoculation of Jrot+ were characterized mainly by the absence of T-lymphocytes (CD3+) on all 537 
the analyzed days and high number of B-lymphocytes on 3 dpi, similar to Jwt. The lesions 538 
produced by the inoculation of JdltBh were characterized mainly by the absence of B-539 
lymphocytes (CD79α+) on all the sampling times. 540 
 541 
Flow cytometer results 542 
The differences detected in the peripheral blood cell counts in the rabbits infected by S. aureus 543 
FdltBr, Jwt, Jrot+ and JdltBh are shown in Fig. 12. The animals infected by the FdtlBr strain had 544 
 
fewer leukocytes (-15.2%) and total lymphocytes (-26.5%) than Jwt, Jrot+ and JdltBh, with 545 
similar counts to one another (Fig. 12A and D).  546 
In the B, T, CD4+, and CD8+ lymphocyte counts, no significant differences were observed 547 
between the rabbits inoculated with the FdltBr strain and Jwt. Both animal groups had more B-548 
lymphocytes and fewer T, CD4+ and CD8+ lymphocytes than Jrot+ and JdltBh (Fig. 12E, F, G 549 
and H). FdltBr and Jwt strains had less CD4+/CD8+ ratio than Jrot+ (Fig. 12J).  550 
The animals infected by the mutant strains presented fewer granulocytes (-34.5%; P<0.05) and 551 
monocytes than those inoculated with Jwt (Fig. 12B and C). For monocytes, the animals 552 
inoculated with Jrot+ and JdltBh had an intermediate level (-23.9% Jrot+ and JdltBh, -50.5% 553 
FdltBr; P<0.05) (Fig. 12C). The CD25+ lymphocytes showed significantly higher counts in the 554 
animals infected by mutant strains FdltBr, Jrot+ and JdltBh (+50.4%, +61.2% and +65%, 555 
respectively; P<0.05) than the rabbits infected by Jwt (Fig. 12I). Finally, strains FdltBr and Jwt 556 
had a higher granulocytes/lymphocytes ratio than Jrot+ and JdltBh (Fig. 12K). 557 
 558 
Discussion 559 
Staphylococcal infections have spread worldwide in hospitals and communities in the last 560 
decades of the 20th century, are multi-resistant to antibiotic strains (especially methicillin-561 
resistant S. aureus – MRSA-) and have become a major health challenge in all industrialized 562 
countries today 1. This problem has also extended to farm animals since 2005, when a livestock-563 
associated MRSA (LA-MRSA) was isolated in pigs 32 and extended to other animal species, 564 
including horses, cattle, poultry or rabbits 33-35. Among the wide range of diseases associated 565 
with community infections that can be caused by S. aureus, SSTIs are one of the most worrying 566 
because they can be a life-threatening process if they are complicated 4-9. SSTIs are 567 
characterized by the formation of bacterial abscesses in dermis, epidermis or subcutaneous 568 
tissues 1. 569 
 
In this context, it would be valuable to have a definitive experimental model that allows the 570 
pathogenesis of the infection to be studied or new therapeutic tools to be tested. Mice are 571 
commonly used for staphylococcal colonization and infection models, mainly for its small size, 572 
easy handling and the abundance of research facilities compared to other larger species like 573 
rabbits 16,36. However, these characteristics alone do not justify its use if the results are not truly 574 
representative. Traditionally, rabbit models of S. aureus infection have been considered optimal 575 
to investigate virulence and host-pathogen interactions, mainly due to certain similarities with 576 
the human species: (1) similar thickness of their skin 14,15; (2) similar immune response to 577 
infection 16; (3) both are naturally infected by S. aureus. For these reasons, we present a rabbit 578 
model because this animal species has its own adapted S. aureus strains 12,35,36, which easily 579 
allow to naturally study staphylococcal infections.  580 
The experimental model was quite respectful of animal health as no animal displayed fever, 581 
loss of weight, septicemia or external signs of disease, except for the expected local lesions at 582 
inoculation points. The model was reproducible, and previously described characteristic 583 
abscesses developed 37, but it also provided more detailed characteristics of lesion development 584 
over time than previously described in the bibliography. Although lesions were observed at all 585 
the studied time points, staphylococcal infection with a Jwt strain was evaluated with this model 586 
at three key time points, 1, 3 and 7 dpi. On 1 dpi it was possible to observe small slightly raised 587 
reddish papules that were histologically characterized by the presence of acute vascular 588 
changes, small organized abscesses, sometimes with inner bacteria and surrounded by 589 
heterophils that were diffusely distributed. One interesting finding was the sharp and one-time 590 
increase in the CD25+ lymphocytes 12 h before (0.5 dpi). As these cells are considered T-591 
regulatory cells 38, it would be interesting to verify to what extent the inflammatory response 592 
described in this intradermal infection is modulated by this cell population. T-regulatory cells 593 
are essential for preventing exacerbation of inflammatory response, but they have been found 594 
 
to lose their activity in the presence of S. aureus, as shown in children with atopic skin 39,40. On 595 
3 dpi superficial lesions lost their initial reddish color and became nodular lesions, and it was 596 
when they acquired their largest volume and had more bacteria. Microscopically, vascular 597 
changes increased in severity, abscesses were surrounded by an eosinophilic necrotic layer in 598 
whose core Splendore-Hoeppli phenomena with inner bacteria were observed. Surrounding the 599 
abscess there were increasing number of T-lymphocytes (CD3+) and macrophages (RAM11+) 600 
compared to previous days, which remained high until 21 dpi., and were related with the 601 
increased number of blood monocytes and lymphocytes on 2 dpi, as previously described 41. 602 
On 7 dpi, 50% of the nodules suffered epidermal necrosis and opened, which triggered a 603 
discharge of pus, and a reduction in both lesion size and the number of isolated bacteria. These 604 
epidermal lesions generated a new inflammatory episode, peripherally characterized by an 605 
increased number of heterophils in blood, which lasted until 14 dpi. In histological terms, 606 
lesions reached their severest point at all the studied locations, with several Splendore-Hoeppli 607 
phenomena surrounded by many T-lymphocytes (CD3+), plasma cells (IgG+) and macrophages 608 
(RAM11+). 609 
Therefore, by studying on 1 dpi and 3 dpi, it would be possible to evaluate the acute 610 
inflammatory response, as well as the subacute inflammatory reaction and initial repair 611 
mechanisms on 7 dpi, which could be useful for the majority of experimental studies on this 612 
topic. For chronic inflammation studies, other later study times (e.g., 14, 21 or 28 dpi) would 613 
be more recommendable, when regenerative modifications were predominant (re-epithelization 614 
and acanthosis in the epidermis, granulation tissue and fibrosis in the dermis, and regeneration 615 
of the cutaneous muscle), and when blood monocytes (2 to 14 dpi) and tissue lymphocytes and 616 
macrophages (3 to 21 dpi) significantly increased, as previously described for chronic 617 
inflammatory processes 41.  618 
 
Several findings in human and animal models have suggested a primarily role for T-cells in 619 
immunity to S. aureus skin infections by enhancing the recruitment of phagocytes 42-44. S. 620 
aureus antigens induce different Th1, Th2 and Th17 cell pathways. Therefore, the role of T-621 
cells in immunity to S. aureus skin infections likely involves multiple T-cell effector cytokines. 622 
As there is a paucity of reagents available to analyze panels of rabbit immune mediators, in this 623 
work it was not possible to accurately characterize the immune response type, but significant 624 
differences were observed in some cytokines after the Jwt strain inoculation. Significant 625 
changes were found in cytokines INF-gamma and IL-18. Cytokine IFN-gamma is a potent 626 
activator of monocytes by increasing their phagocytic activity in tissues. 41. Despite this 627 
cytokine increasing on 21 dpi, it became significant only on 0.5 dpi. IL-18 has been associated 628 
with atopic dermatitis expelled by S. aureus 45. Although S. aureus is capable of causing the 629 
release of IL-18 from keratinocytes 46, in this work an increase was detected only in plasma, 630 
but not in skin. An increase in IL-4 in plasma and skin was noted, especially after 21 days. S. 631 
aureus is able to inhibit the response of T-cell responses and to induce Th2 cell responses by 632 
producing IL-4 47 in relation to chronic inflammations 41. 633 
The difficulty in developing an experimental model that reproduces an immune response under 634 
natural conditions might be related to the effect of the origin of both the bacteria and animal 635 
species used as hosts on the infective dose 48. In general, a higher dose is necessary to infect 636 
animals with the S. aureus strains obtained from a different species (e.g. human bacteria CA-637 
MRSA USA300 in mice: >5.0x108 CFU 49). In such cases, animal models can be unreliable 638 
predictors of either the potential success of therapeutic or preventive interventions or the roles 639 
played by specific determinants of bacterial virulence in infection 2. Only a few standardized 640 
studies about the number of bacteria needed to begin infection can be found 50. Schmid-Hempel 641 
and Frank 50 proposed an infective S. aureus dose of 105-106 bacteria and classified it as a high-642 
infective dose microorganism. In fact it has been reported that inoculation with less than 5x108 643 
 
CFU of USA300 does not result in reproducible abscesses in rabbits 17,49. Our results agree with 644 
this observation when we used human strains (not adapted to rabbit), but disagree when rabbit 645 
strains were employed, which can generate dermal lesions with only 300 CFU by simulating 646 
natural infection. Moreover, when high doses of human strain Fwt (> 106 CFU) were used with 647 
this model, the generated lesions differed from those observed for low doses of rabbit wild-type 648 
strains: lesions rapidly evolved and skin necrotic phenomena (dermonecrosis) predominated 649 
and, in histological terms, the presence of thrombosis and the absence of Splendore-Hoeppli 650 
phenomena or a peripheral eosinophilic layer were observed on 3 dpi (JM Corpa, personal 651 
communication, Supplemental Figure 1). Similar results have been reported by other authors 652 
17, who recognized that using such high doses would result in rapidly progressive infection, 653 
which would vastly differed from that typically encountered in clinical situations, and the 654 
results could not be extrapolated to humans. These skin necrotic phenomena are probably 655 
caused by the mass production of bacterial toxins, which is far removed from what actually 656 
happens in natural infection. This hypothesis would support the results observed in the present 657 
study with the mutants (JΔcoaΔvwb, JΔhla, JΔpsmα, JΔagr) employed to evaluate their 658 
contribution to the development and characteristics of abscesses. Studies carried out in rabbits, 659 
and mainly in mice, using Dhla mutants have resulted in reduced virulence in animal models of 660 
dermonecrotic skin infection. Moreover, immunization with Hla-specific antisera significantly 661 
reduces the size of skin lesions and prevents dermonecrosis 11,17,51,52, and similar results have 662 
been obtained with mutants in psm-a 53. Surprisingly, when the herein described skin infection 663 
model was used, mutants Dhla and Δpsma produced the same percentage of lesions as the wild-664 
type strain, and even became macroscopically severer for Dhla regarding Jwt. Toxins and other 665 
virulence factors, such as a-toxin, PSM-a and PSM-b, are produced as a result of increased 666 
bacterial population density and environmental conditions, partly under a quorum-sensing 667 
control through different regulators 54-56. Therefore, the effect observed in previous works with 668 
 
either the Dhla or the Dpsma mutant could be due to the use of high doses of bacteria to produce 669 
lesions, which would favor the rapid production of numerous toxins, and would make the effect 670 
of the toxin more evident. The absence of an effect on the Dagr mutant would follow the same 671 
hypothesis. In S. aureus, the majority of quorum-sensing components are coded by the 672 
accessory gene regulator (Agr) system. This regulation is important for acute disease to develop 673 
37, but we showed that Agr was dispensable in intradermal infections of rabbits. Agr suppresses 674 
the expression of the repressor of toxins (rot) at a high cell density 57, which could also influence 675 
the virulence of the Dagr mutant. However, rabbit strains have a natural loss-of-function 676 
mutation in rot, which increases the severity and infectivity of the rabbit strain. This could 677 
justify the FdltBr strain (with functional rot) producing milder lesions than the wild-type strain.  678 
A histological characteristic observed from 3 dpi in the lesions produced by the strain wild-type 679 
was an eosinophilic necrotic layer in whose core Splendore-Hoeppli phenomena with inner 680 
bacteria were observed. These phenomena have been previously described as an electron-dense, 681 
granular and amorphous pseudocapsule. This pseudocapsule constitutes a barrier for immune 682 
cells by preventing them from penetrating the staphylococcal abscess community (SAC), where 683 
bacteria replicate without interference and are partially composed of prothrombin and 684 
fibrinogen that separate bacteria from leukocytes 37,58,59. As the DcoaDvwb mutant was able to 685 
produce lesions like Jwt, the absence of these two clotting factors secreted by S. aureus does 686 
not seem essential for abscesses to develop in rabbits. Despite all the employed mutants 687 
(JΔcoaΔvwb, JΔhla, JΔpsmα, JΔagr) being able to generate similar lesions to the wild type in 688 
size and degree of severity terms, albeit in different percentages, they all triggered a delay in 689 
the evolution of histological lesions compared to the wild type. This could indicate that their 690 
mutations affected abscess development, but other factors also had to be involved in their 691 
development. More studies are needed to learn the specific role of these and other virulence 692 
factors in S. aureus infection development. 693 
 
The utility of this model was corroborated when a human strain, modified to infect rabbits 694 
(“rabbitized”), was inoculated (FdltBr). This adaptation to the host seemed essential because 695 
neither macro- nor microscopic lesions developed when the human Fwt strain was inoculated 696 
with 300 CFU 13, while the modified strain (FdltBr) was able to produce similar lesions to the 697 
wild strain adapted to rabbit (Jwt). 698 
Finally, although mouse models have been presented as the “gold standard” to study 699 
staphylococcal infections in humans, along with their therapy and prevention 60, we propose a 700 
low-infective-dose rabbit model as a more representative and realistic model, in which the effect 701 
of both homologous and heterologous strains can be proven. 702 
 703 
Author contributions 704 
Conceptualization: Laura Selva, Juan M. Corpa, David Viana. Formal analysis: Juan J. Pascual, 705 
Alberto Arnau-Bonachera, Juan M. Corpa, David Viana. Funding acquisition: Laura Selva, 706 
Juan M. Corpa, David Viana. Methodology: Asunción Muñoz-Silvestre, Mariola Penadés, 707 
Laura Selva, Sara Pérez-Fuentes, Elena Moreno, Ana García-Quirós, Juan J. Pascual, Alberto 708 
Arnau-Bonachera, Agustín Barragán, Juan M. Corpa, David Viana. Project administration: Juan 709 
M. Corpa. Supervision: Juan M. Corpa, David Viana. Writing – original draft: Asunción 710 
Muñoz-Silvestre, Alberto Arnau-Bonachera, Juan M. Corpa, David Viana. Writing – review & 711 
editing: Alberto Arnau-Bonachera, Juan J. Pascual, Juan M. Corpa, David Viana. Juan M. 712 
Corpa and David Viana are the guarantors of this work and, as such, had full access to all of the 713 
data in the study and take responsibility for the integrity of the data and the accuracy of the data 714 
analysis. 715 
 716 
  717 
 
Acknowledgments 718 
We thank José R. Penadés for their support with the development of this work and comments 719 
on the manuscript and Laura Núñez for excellent technical assistance. 720 
The authors declare no competing financial interests.  721 
  722 
 
References 723 
1. Kobayashi SD, Malachowa N, DeLeo FR: Pathogenesis of Staphylococcus aureus 724 
Abscesses. Am J of Pathol 2015, 185:1518–1527.  725 
2. Lowy FD: How Staphylococcus aureus adapts to its host. N Engl J Med 2011, 364:1987–726 
1990.  727 
3. Peschel A, Otto M: Phenol-soluble modulins and staphylococcal infection. Nat Vet 728 
Microbiol 2013, 11:667–673. 729 
4. Eiff von C, Becker K, Machka K, Stammer H, Peters G: Nasal carriage as a source of 730 
Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001, 344:11–16.  731 
5. Said-Salim B, Dunman PM, McAleese FM, Macapagal D, Murphy E, McNamara PJ, 732 
Arvidson S, Foster TJ, Projan SJ, Kreiswirth BN: Global regulation of Staphylococcus 733 
aureus genes by Rot. J Bacteriol 2003, 185:610–619.  734 
6. Gao J, Stewart GC: Regulatory elements of the Staphylococcus aureus protein A (Spa) 735 
promoter. J Bacteriol 2004, 186:3738–3748.  736 
7. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, 737 
Harriman K, Harrison LH, Lynfield R, Farley MM, Active Bacterial Core Surveillance 738 
Program of the Emerging Infections Program Network: Methicillin-resistant 739 
Staphylococcus aureus disease in three communities. N Engl J Med 2005, 352:1436–740 
1444.  741 
8. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF: Community-associated meticillin-742 
resistant Staphylococcus aureus. Lancet 2010, 375:1557–1568.  743 
9. Talan DA, Krishnadasan A, Gorwitz RJ, Fosheim GE, Limbago B, Albrecht V, Moran 744 
GJ, EMERGEncy ID Net Study Group: Comparison of Staphylococcus aureus from skin 745 
and soft-tissue infections in US emergency department patients, 2004 and 2008. Clin 746 
Infect Dis 2011, 53:144–149.  747 
10. Bae I-G, Tonthat GT, Stryjewski ME, Rude TH, Reilly LF, Barriere SL, Genter FC, 748 
Corey GR, Fowler VG: Presence of genes encoding the panton-valentine leukocidin 749 
exotoxin is not the primary determinant of outcome in patients with complicated skin 750 
 
and skin structure infections due to methicillin-resistant Staphylococcus aureus: results 751 
of a multinational trial. J Clin Microbiol 2009, 47:3952–3957.  752 
11. Kennedy AD, Wardenburg JB, Gardner DJ, Long D, Whitney AR, Braughton KR, 753 
Schneewind O, DeLeo FR: Targeting of Alpha‐Hemolysin by Active or Passive 754 
Immunization Decreases Severity of USA300 Skin Infection in a Mouse Model. J Infect 755 
Dis 2010, 202:1050–1058.  756 
12. Viana D, Selva L, Segura P, Penadés JR, Corpa JM: Genotypic characterization of 757 
Staphylococcus aureus strains isolated from rabbit lesions. Vet Microbiol 2007, 758 
121:288–298.  759 
13. Viana D, Comos MA, McAdam PR, Ward MJ, Selva L, Guinane CM, González-Muñoz 760 
BM, Tristan A, Foster SJ, Fitzgerald JR, Penadés JR: A single natural nucleotide 761 
mutation alters bacterial pathogen host tropism. Nat Genet 2015, 47:361–366.  762 
14. Oznurlu Y, Celik I, Sur E, Telatar T, Ozparlak H: Comparative skin histology of the 763 
white new zealand and angora rabbits: Histometrical and immunohistochemical 764 
evaluations. JAVA 2009, 8:1694–1701.  765 
15. Jung EC, Maibach HI: Animal models for percutaneous absorption. J Appl Toxicol, 766 
2015, 35:1–10.  767 
16. Malachowa N, Kobayashi SD, Porter AR, Braughton KR, Scott DP, Gardner DJ, 768 
Missiakas DM, Schneewind O, DeLeo FR: Contribution of Staphylococcus aureus 769 
Coagulases and Clumping Factor A to Abscess Formation in a Rabbit Model of Skin and 770 
Soft Tissue Infection. PLoS ONE 2016, 11:e0158293–14.  771 
17. Le VTM, Tkaczyk C, Chau S, Rao RL, Dip EC, Pereira-Franchi EP, Cheng L, Lee S, 772 
Koelkebeck H, Hilliard JJ, Yu XQ, Datta V, Nguyen V, Weiss W, Prokai L, O'Day T, 773 
Stover CK, Sellman BR, Diep BA: Critical Role of Alpha-Toxin and Protective Effects 774 
of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure 775 
Infections. Antimicrob Agents Chemother 2016, 60:5640–5648.  776 
18. Otto M: Staphylococcus aureus toxins. Curr Opin Microbiol 2014, 17:32–37.  777 
 
19. Collins LV, Kristian SA, Weidenmaier C, Faigle M, van Kessel KPM, van Strijp JAG, 778 
Götz F, Neumeister B, Peschel A: Staphylococcus aureus strains lacking D-alanine 779 
modifications of teichoic acids are highly susceptible to human neutrophil killing and 780 
are virulence attenuated in mice. J Infect Dis 2002, 186:214–219. 781 
20.  Novick RP: Genetic systems in staphylococci. Meth Enzymol 1991, 204:587–636.  782 
21. Lindsay JA, Ruzin A, Ross HF, Kurepina N, Novick RP: The gene for toxic shock toxin 783 
is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol 784 
Microbiol 1998, 29:527–543. 785 
22. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K: 786 
Current protocols in molecular biology. New York, John Wiley & Sons, 1990.  787 
23. Arnaud M, Chastanet A, Débarbouillé M: New vector for efficient allelic replacement in 788 
naturally nontransformable, low-GC-content, gram-positive bacteria. Appl Environ 789 
Microbiol 2004, 70:6887–6891.  790 
24. Ubeda C, Maiques E, Knecht E, Lasa I, Novick RP, Penadés JR: Antibiotic-induced SOS 791 
response promotes horizontal dissemination of pathogenicity island-encoded virulence 792 
factors in staphylococci. Mol Microbiol 2005, 56:836–844.  793 
25. Li M, Cheung GYC, Hu J, Wang D, Joo H-S, DeLeo FR, Otto M: Comparative Analysis 794 
of Virulence and Toxin Expression of Global Community‐Associated Methicillin‐795 
Resistant Staphylococcus aureus Strains. J Infect Dis 2010, 202:1866–1876.  796 
26. Bunce C, Wheeler L, Reed G, Musser J, Barg N: Murine model of cutaneous infection 797 
with gram-positive cocci. Infect Immun 1992, 60:2636–2640.  798 
27. Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, Welty D, Long RD, 799 
Dorward DW, Gardner DJ, Lina G, Kreiswirth BN, DeLeo FR: Is Panton‐Valentine 800 
Leukocidin the Major Virulence Determinant in Community‐Associated Methicillin‐801 
Resistant Staphylococcus aureus Disease? J Infect Dis 2006, 194:1761–1770.  802 
28. Jeklova E, Leva L, Faldyna M: Lymphoid organ development in rabbits: Major 803 
lymphocyte subsets. Dev Comp Immunol 2007, 31:632–644.  804 
 
29. Guerrero I, Ferrian S, Blas E, Pascual JJ, Cano JL, Corpa JM: Evolution of the peripheral 805 
blood lymphocyte populations in multiparous rabbit does with two reproductive 806 
management rhythms. Vet Immunol Immunopath 2011, 140:75–81.  807 
30. Hulstaert F, Hannet I, Deneys V, Munhyeshuli V, Reichert T, De Bruyere M, Strauss K: 808 
Age-related changes in human blood lymphocyte subpopulations. II. Varying kinetics of 809 
percentage and absolute count measurements. Clin Immunol Immunopathol 1994, 810 
70:152–158.  811 
31. McCullagh P, Nelder JA: Generalized Linear Models. 2nd ed. Chapman & Hall/CRC, 812 
1989.  813 
32. Armand-Lefevre L, Ruimy R, Andremont A: Clonal comparison of Staphylococcus 814 
aureus isolates from healthy pig farmers, human controls, and pigs. Emerging Infect Dis 815 
2005, 11:711–714.  816 
33. Graveland H, Duim B, van Duijkeren E, Heederik D, Wagenaar JA: Livestock-817 
associated methicillin-resistant Staphylococcus aureus in animals and humans. Int J Med 818 
Microbiol 2011, 301:630–634.  819 
34. Aires-de-Sousa M: Methicillin-resistant Staphylococcus aureus among animals: current 820 
overview. Clin Microbiol Infect 2017, 23 (6) :373–380.  821 
35. Moreno-Grúa E, Pérez-Fuentes S, Muñoz-Silvestre A, Viana D, Fernández-Ros AB, 822 
Sanz-Tejero C, Corpa JM, Selva L: Characterization of Livestock-Associated 823 
Methicillin-Resistant Staphylococcus aureus Isolates Obtained From Commercial 824 
Rabbitries Located in the Iberian Peninsula. Front Microbiol 2018, 9:1812.  825 
36. Montgomery CP, Daniels M, Zhao F, Alegre M-L, Chong AS, Daum RS: Protective 826 
immunity against recurrent Staphylococcus aureus skin infection requires antibody and 827 
interleukin-17A. Infect Immun 2014, 82:2125–2134.  828 
37. Viana D, Selva L, Callanan JJ, Guerrero I, Ferrian S, Corpa JM: Strains of 829 
Staphylococcus aureus and pathology associated with chronic suppurative mastitis in 830 
rabbits. Vet J 2011, 190:403–407.  831 
 
38. Cheng AG, DeDent AC, Schneewind O, Missiakas D: A play in four acts: 832 
Staphylococcus aureus abscess formation. Trends Microbiol 2011, 19:225–232.  833 
39. Chen X, Du Y, Lin X, Qian Y, Zhou T, Huang Z: CD4+CD25+ regulatory T cells in 834 
tumor immunity. Int Immunopharmacol 2016, 34:244–249.  835 
40. Bekeredjian-Ding I: Deciphering the significance of the T-cell response to 836 
Staphylococcus aureus. Fut Microbiol 2017, 12:1023–1026.  837 
41. Laborel-Préneron E, Bianchi P, Boralevi F, Lehours P, Fraysse F, Morice-Picard F, 838 
Sugai M, Sato'o Y, Badiou C, Lina G, Schmitt A-M, Redoulès D, Casas C, Davrinche 839 
C: Effects of the Staphylococcus aureus and Staphylococcus epidermidis Secretomes 840 
Isolated from the Skin Microbiota of Atopic Children on CD4+ T Cell Activation. PLoS 841 
ONE, 2015, 10:e0141067–16.  842 
42. Ackermann MR: Chapter 3 - Inflammation and Healing. Sixth Edition. Pathologic Basis 843 
of Veterinary Disease. Elsevier Inc, 2017, pp. 73–131.e2.  844 
43. Krishna S, Miller LS: Innate and adaptive immune responses against Staphylococcus 845 
aureus skin infections. Semin Immunopathol 2011, 34:261–280.  846 
44. Liu Q, Mazhar M, Miller LS: Immune and Inflammatory Reponses to Staphylococcus 847 
aureus Skin Infections. Curr Dermatol Rep, 2018,7 (4):338–349.  848 
45. Miller LS, Cho JS: Immunity against Staphylococcus aureus cutaneous infections. Nat 849 
Rev Immunol 2011, 11:505–518.  850 
46. Terada M, Tsutsui H, Imai Y, Yasuda K, Mizutani H, Yamanishi K, Kubo M, Matsui K, 851 
Sano H, Nakanishi K: Contribution of IL-18 to atopic-dermatitis-like skin inflammation 852 
induced by Staphylococcus aureus product in mice. Proc Natl Acad Sci USA 2006, 853 
103:8816–8821.  854 
47. Syed AK, Reed TJ, Clark KL, Boles BR, Kahlenberg JM: Staphylococcus aureus 855 
Phenol-Soluble Modulins Stimulate the Release of Proinflammatory Cytokines from 856 
Keratinocytes and Are Required for Induction of Skin Inflammation. Infect Immun 2015, 857 
83:3428–3437.  858 
 
48. Laouini D, Kawamoto S, Yalcindag A, Bryce P, Mizoguchi E, Oettgen H, Geha RS: 859 
Epicutaneous sensitization with superantigen induces allergic skin inflammation. J 860 
Allergy Clin Immunol 2003, 112:981–987.  861 
49. Holtfreter S, Radcliff FJ, Grumann D, Read H, Johnson S, Monecke S, Ritchie S, Clow 862 
F, Goerke C, Bröker BM, Fraser JD, Wiles S: Characterization of a mouse-adapted 863 
Staphylococcus aureus strain. PLoS ONE 2013, 8:e71142.  864 
50. Kobayashi SD, Malachowa N, Whitney AR, Braughton KR, Gardner DJ, Long D, 865 
Bubeck Wardenburg J, Schneewind O, Otto M, DeLeo FR: Comparative analysis of 866 
USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J 867 
Infect Dis 2011, 204:937–941.  868 
51. Schmid-Hempel P, Frank SA: Pathogenesis, virulence, and infective dose. PLoS Pathog 869 
2007, 3:1372–1373.  870 
52. Inoshima N, Wang Y, Bubeck Wardenburg J: Genetic Requirement for ADAM10 in 871 
Severe Staphylococcus aureus Skin Infection. J Invest Dermatol 2012, 132:1513–1516.  872 
53. Tkaczyk C, Hamilton MM, Datta V, Yang XP, Hilliard JJ, Stephens GL, Sadowska A, 873 
Hua L, O’Day T, Suzich J, Stover CK, Sellman BR: Staphylococcus aureus Alpha Toxin 874 
Suppresses Effective Innate and Adaptive Immune Responses in a Murine 875 
Dermonecrosis Model. PLoS ONE 2013, 8:e75103–e75112.  876 
54. Wang R, Braughton KR, Kretschmer D, Bach T-HL, Queck SY, Li M, Kennedy AD, 877 
Dorward DW, Klebanoff SJ, Peschel A, DeLeo FR, Otto M: Identification of novel 878 
cytolytic peptides as key virulence determinants for community-associated MRSA. Nat 879 
Med 2007, 13:1510–1514.  880 
55. Recsei P, Kreiswirth B, O'Reilly M, Schlievert P, Gruss A, Novick RP: Regulation of 881 
exoprotein gene expression in Staphylococcus aureus by agar. Mol Gen Genet 1986, 882 
202:58–61.  883 
56. Rainard P, Gitton C, Chaumeil T, Fassier T, Huau C, Riou M, Tosser-Klopp G, Krupova 884 
Z, Chaize A, Gilbert FB, Rupp R, Martin P: Host factors determine the evolution of 885 
infection with Staphylococcus aureus to gangrenous mastitis in goats. Vet Res 2018, 49: 886 
72.  887 
 
57. Salam AM, Quave CL: Targeting Virulence in Staphylococcus aureus by Chemical 888 
Inhibition of the Accessory Gene Regulator System In Vivo. mSphere 2018, 3:1193.  889 
58. Haag AF, Bagnoli F: The Role of Two-Component Signal Transduction Systems in 890 
Staphylococcus aureus Virulence Regulation. Curr. Top. Microbiol. Immunol 2017, 891 
409:145–198.  892 
59. Cheng AG, Kim HK, Burts ML, Krausz T, Schneewind O, Missiakas DM: Genetic 893 
requirements for Staphylococcus aureus abscess formation and persistence in host 894 
tissues. FASEB J 2009, 23:3393–3404.  895 
60. Cheng AG, McAdow M, Kim HK, Bae T, Missiakas DM, Schneewind O: Contribution 896 
of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS 897 
Pathog 2010, 6:e1001036. 898 
61. Kim HK, Missiakas D, Schneewind O: Mouse models for infectious diseases caused by 899 
Staphylococcus aureus. J Immunol Methods 2014, 410:88–99.  900 
  901 
 
Figure Legends 902 
Figure 1. Representation of abscess evolution after experimental infection with S. aureus (Jwt 903 
strain) with time. A: 0 days postinoculation (dpi). Intradermal inoculation of 300 CFU of S. 904 
aureus. Colored bars and numbers indicate the different histological parts of skin (1: epidermis; 905 
2: superficial dermis; 3: deep dermis; 4: cutaneous muscle). B: 0.5 dpi. 1: Externally, reddish 906 
macule. 2: Mild vascular phenomena (edema and hemorrhages). 3: Migration of hererophils 907 
mainly from deep vessels (arrows) and grouping at the inoculation point. 4: Small hemorrhages. 908 
C: 1 dpi. 1: External slightly elevated reddish papule. 2: Mild to moderate edema and 909 
hemorrhages. 3: Initial abscess structured as a center of eosinophilic necrosis, with some 910 
bacteria surrounded by diffusely distributed heterophils. 4: Muscular cells moderately 911 
infiltrated by heterophils. D: 2 dpi. 1: External reddish and elevated nodule and mild epidermal 912 
acanthosis, 2: Moderate edema and hemorrhages. 3: Well-defined abscess composed of a center 913 
of eosinophilic necrosis with bacteria, surrounded by a dense layer of heterophils. 4: Muscle 914 
cells infiltrated by numerous heterophils that induce their separation and necrosis. E: 3 dpi. 1: 915 
Big dark nodule with epidermal necrosis and acanthosis. 2: Severe vascular phenomena. 3: 916 
Abscess with the presence of multiple Splendore-Hoeppli phenomena and an external layer of 917 
eosinophilic necrosis. 4: Myocytes severely infiltrated by heterophils causing their 918 
degeneration. F: 7 dpi. 1: Necrosis and skin ulceration allowing the outflow of purulent content 919 
and acanthosis in the periphery to the ulcer. 2: Very severe vascular phenomena. 3: Splendore-920 
Hoeppli phenomena merging with one another and the presence of a thin eosinophilic layer of 921 
necrosis surrounding the entire abscess. 4: Cutaneous muscle interrupted by the presence of 922 
numerous heterophils and round cells. G: 14 dpi. 1: External lack of hair (alopecy), ulcer 923 
reepitelization and moderate to severe acanthosis. 2: Absence of skin adnexa and moderate 924 
vascular phenomena. 3: Presence of immature granulation tissue (numerous small neo-vessels 925 
and abundant connective tissue) and some scattered Splendore-Hoeppli phenomena. 4: Atrophy 926 
of myocytes. H: 21 dpi. 1: External alopecy, very severe acanthosis. 2 and 3: Abundant mature 927 
granulation tissue. 4: Interstitial fibrosis and atrophy of myocytes. I: 28 dpi. 1: External small 928 
area of alopecy and moderate acanthosis. 2: Invasion of skin appendages to the periphery of the 929 
scar. 3: Mature granulation tissue with abundant fibrous tissue. 4: Completely regenerated 930 




Figure 2. Correspondence between the gross (external and internally) and histological lesions 934 
during the experiment of the wild-type (Jwt) S. aureus strain inoculation. A: external aspect; B: 935 
sagittal cut of formalin fixed tissue; C: microscopically low magnification view stained with 936 
Hematoxilin-Eosin (H&E). 937 
 938 
Figure 3. Colony-forming units after intradermal inoculation with Jwt (n = 10 animals per 939 
time). a-c The means not sharing superscript significantly differ (P<0.05). Error bars correspond 940 
to the standard error for each least square mean. 941 
 942 
Figure 4. Different histological characteristics of lesions throughout infection with the Jwt S. 943 
aureus strain. A (0.5 dpi): Slight increase in the number of heterophils. Deep dermis. H&E. 944 
Scale bar = 200 μm. B (1dpi): Abscess surrounded by numerous diffusely distributed 945 
heterophils. Skin. H&E. Scale bar = 1 mm. C (2dpi): Well-defined abscess characterized by a 946 
center of eosinophilic necrosis, with numerous coccoid bacteria inside (insert). Skin and 947 
bacteria (insert). H&E. Scale bar = 1 mm (skin) and 50 μm (insert). D (2pi): Muscular 948 
degeneration caused by the intense interstitial infiltration of heterophils. Cutaneous muscle. 949 
H&E. Scale bar = 100 μm. E (3dpi): Necrosis of epidermis. Epidermis. H&E. Scale bar = 200 950 
μm. F (3dpi): A bacterial colony surrounded by star-shaped homogeneous eosinophilic material 951 
and an external layer of inflammatory cells. Splendore-Hoeppli phenomenon. H&E. Scale bar 952 
= 20 μm. G (3dpi): Abscess internally composed of the fusion of several Splendore-Hoeppli 953 
phenomena, surrounded by a thin eosinophilic layer of necrosis. Skin. H&E. Scale bar = 1 mm. 954 
H (3dpi): Severe atrophy of myocytes, infiltrated by connective tissue (left) versus normal 955 
muscular tissue (right). Cutaneous muscle. Masson’s trichrome stain. Scale bar = 200 μm. I 956 
(7dpi): Significant increase in the number of cells with numerous mitosis (white arrows) on the 957 
basal layer of the epidermis (epidermal hyperplasia or acanthosis), compared to normal 958 
epidermis (insert). Epidermis. H&E. Scale bars = 100 μm (acanthosis) and 50 μm (insert). J 959 
(14dpi): Severe inflammatory reaction associated with an ulcer and epidermal hyperplasia on 960 
the border. Epidermis. H&E. Scale bar = 200 μm. K (14dpi): Repair of the lesion characterized 961 
by acanthosis, absence of skin adnexa (left) and presence of abundant granulation tissue 962 
composed of numerous vessels and fibrous tissue (right). Skin (left) and deep dermis (right). 963 
H&E. Scale bars = 500 μm (left) and 200 μm (right). L (28dpi): Epithelial hyperplasia (arrow 964 
heads) and dermis with abundant fibrous tissue and blood vessels and scarce heterophils and 965 
some small hemorrhages (asterisk). The periphery of the lesion is invaded by hair follicles 966 
(arrows). Epidermis and dermis. H&E. Scale bar = 200 μm. 967 
 
 968 
Figure 5. Hyperplasia of the epithelium with the presence of numerous mitosis in the basal 969 
layer (white arrows) on 21 days postinfection with the Jwt S. aureus strain. Insert: Normal 970 
epithelium. H&E. Scale bars: 100 µm.  971 
 972 
Figure 6. Evolution of the counts of CD3+(A), IgG+(B) and RAM11+(C) cells 973 
immunochemically marked in the skin samples and total leukocytes (D), total lymphocytes (E), 974 
granulocytes (F), monocytes (G), lymphocytes B (H) and lymphocytes T CD25+ (I) (x 106/L) 975 
in peripheral blood after intradermal inoculation with the Jwt strain (n = 10 animals per day). a-976 
e The means that do not share a superscript in the same figure significantly differ (P<0.05) for 977 
each postinoculation time. Error bars correspond to the standard error for each least square 978 
mean. 979 
 980 
Figure 7. Severity assessment of gross lesions on day 7 after intradermal inoculation with 981 
different mutants (JΔcoaΔvwb, n=16; JΔhla, n=15; JΔpsmα n=8; JΔagr n=15) vs. Jwt (high 982 
virulent) and Jrot+ (low virulent) strains. a, b Within an experiment, the groups not sharing letters 983 
above the bar significantly differ (P<0.05).  984 
 985 
Figure 8. Presence of the main histological characteristics (Splendore-Hoeppli phenomena, A; 986 
heterophils surrounding the abscesses, B; and complete eosinophilic layers, C) on day 7 after 987 
intradermal inoculation with different mutant strains (JΔcoaΔvwb, JΔhla, JΔpsmα and JΔagr). 988 
Evaluated as variation in relation to intradermal inoculation with Jwt for: JΔcoaΔvwb (n=16), 989 
JΔhla (n=15), JΔpsmα (n=8), JΔagr (n=15). * Significant variation in relation to intradermal 990 
inoculation with Jwt (P<0.05).  991 
 992 
Figure 9. Mean severity assessment of gross lesions after intradermal inoculation with different 993 
strains (FdltBr, Jwt, Jrot+ and JdltBh; n= 30 animals per strain). Assessment is represented as 994 
the percentage at four levels: Absence, Mild, Moderate, Severe. a, b The groups not sharing 995 
letters above the bar significantly differ (P<0.05).  996 
 997 
Figure 10. Colony-forming units after intradermal inoculation with different strains of S. 998 
aureus [FdltBr, Jwt, Jrot+; n=10 animals per strain and day]. a-d The means not sharing 999 
 
superscript significantly differ (P<0.05). Error bars correspond to the standard error for each 1000 
least square mean. 1001 
 1002 
Figure 11. Severity assessment of abscesses (heterophils organized) histologically (A) after 1003 
infections with strains FdltBr, Jwt, Jrot+ and JdltBh (n=30 animals per strain). Assessment is 1004 
represented at four levels: Absence, Mild, Moderate, Severe. The groups not sharing letters (a, 1005 
b, c, d, e) above the bar significantly differ (P<0.05). dpi: days postinfection. Evolution of the 1006 
counts of T-lymphocytes CD3+(B), B-lymphocytes CD79a+ (C), plasma cells IgG+(D) and 1007 
macrophages RAM11+(E) immunochemically marked in skin samples after infection with 1008 
strains FdltBr, Jwt, Jrot+ and JdltBh. a-d The means in a graph not sharing superscript 1009 
significantly differ (P<0.05). Error bars correspond to the standard error for each least square 1010 
mean. 1011 
 1012 
Figure 12. Effect of S. aureus strains on leukocyte population counts (A-I) in peripheral blood 1013 
and CD4+/CD8 (J) and granulocytes/lymphocytes (K) ratios after intradermal inoculation with 1014 
strains FdltBr, Jwt, Jrot+ and JdltBh; n=30 animals per strain. a, b, c The means in a same graph 1015 
not sharing superscript significantly differ at P<0.05. G/L: Granulocytes/Lymphocytes. 1016 
 1017 
  1018 
 
Table 1. Number of rabbits inoculated with different S. aureus strains, sampling days, expected 1019 






Jwt 90 0, ½, 1, 2, 3, 
7, 14, 21, 28 
To describe the model in detail after the intradermal inoculation 
of a virulent S. aureus strain of rabbit origin. 
1a 
JΔcoaΔvwb 10 7 Both coagulases Coa and vWbp are required for abscesses to 
form. A reduction in the virulence of JΔcoaΔvwb and the 
presence of differences in the morphology of abscesses were 
expected. 
1b 
JΔhla 10 7 a-Hemolysin is a cytolitic toxin that promotes dermonecrosis 
in animal skin infections 1. A reduction in abscess size and 
fewer and milder dermonecrotic lesions were expected. 
1b 
JΔpsmα 10 7 PSMα performs cytolytic (lysis of erythrocytes and neutrophils) 
and immunomodulation (induces tolerogenic phenotypes in 
dendritic cells and inhibits TH1 differentiation) activities 
3. 
Diminished reduction in the severity of dermal lesions was 
expected. 
1b 
JΔagr 10 7 Agr regulates most S. aureus toxins and exoenzymes 18. A 
dysfunctional strain in this global virulence regulator should 
reduce the high toxicity in strongly aggressive S. aureus strains.  
1b 
FdltBr 30 1, 3, 7 F is a human ST121 strain that does not infect rabbits 13. After 
its “rabbitization” (introduction of most 5’ nonsynonymous 
SNP at the dltB* locus from rabbit strains), the virulence of 
FdltBr was expected to be similar to that of Jwt. 
2 
Jrot+ 30 1, 3, 7 rot is a global virulence regulator, a repressor of toxins 5, which 
is altered in rabbits. Its restoral is expected to make Jrot+ less 
virulent than Jwt. 
2 
JdltBh 30 1, 3, 7 After the reversion of the three identified dltB SNPs (dltBh) in 
a rabbit strain J (Jwt), loss of infectivity was expected 13. 
2 
*The dltB gene is involved in the resistance of S. aureus to positively charged antimicrobial peptides, such 1021 





  1027 
 
Table 2. The oligonucleotides used in this study.  1028 
 1029 
Oligonucleotides Description Sequence  
Coa-1m Checking the coa mutants in Jwt and FdltBr strains 
by inside-inside PCR. 
5’−ATAGAGATGCTGGTACAGG−3’ 
Coa-2c Checking the coa mutants in Jwt and FdltBr strains 
by inside-inside PCR. 
5’−GCTTCCGATTGTTCGATGC−3’ 
Coa-5mB Deletion of coa (Δcoa) in Jwt and FdltBr strains. 5’ 
flanking region. 
5’−cgcggatccTCATGACGATACTTTCAGAGG−3’ 
Coa-6c Deletion of coa (Δcoa) in Jwt and FdltBr strains. 5’ 
flanking region. 
5’−CCCAATCTACATTAAAGAAAC−3’ 




Coa-8cE Deletion of coa (Δcoa) in Jwt and FdltBr strains. 3’ 
flanking region. 
5’−ccggaattcGTACGAATGTGAATGGTGGC−3’ 
Coa-11m Checking the coa mutants in Jwt and FdltBr strains 
by outside-outside PCR. 
5’−CATACTTCGATCGTTCTATAAG−3’ 
Coa-12c Checking the coa mutants in Jwt and FdltBr strains 
by outside-outside PCR. 
5’−TTGCATCTATTAAAGAAGTAGG−3’ 
PSMa-1mB Deletion of psma locus (Δpsma) in Jwt and FdltBr 
strains. 5’ flanking region. 
5’−cgggatccACATGTTGACCATGAATACC−3’ 
PSMa-2c Deletion of psma locus (Δpsma) in Jwt and FdltBr 
strains. 5’ flanking region. 
5’−gtattcaattcgcttaaattattCATTAAGATTACCTCCT
TTGC−3’ 
PSMa-3m Deletion of psma locus (Δpsma) in Jwt and FdltBr 
strains. 3’ flanking region. 
5’-AATAATTTAAGCGAATTGAATAC−3’ 
PSMa-4cE Deletion of psma locus (Δpsma) in Jwt and FdltBr 
strains. 3’ flanking region. 
5’−ccggaattcAATTGTGGCTTAATTGTTTGC−3’ 
PSMa-5m Checking the psma locus mutants in Jwt and 
FdltBr strains by inside-inside PCR.  
5’−GCAAAGGAGGTAATCTTAATG−3’ 
PSMa-6m Checking the psma locus mutants in Jwt and 
FdltBr strains by outside-outside PCR. 
5’−TACAAAGCCAGCTAATAACC−3’ 
PSMa-7c Checking the psma locus mutants in Jwt and 
FdltBr strains by outside-outside PCR. 
5’−AATGGCAAATTAGACCAGC−3’ 
PSMa-8c Checking the psma locus mutants in Jwt and 
FdltBr strains by inside-inside PCR. 
5’−CGAATTCCATGTGAATGGC−3’ 
vwb-1mB Deletion of vwb (Δvwb) in Jwt and FdltBr strains. 
5’ flanking region. 
5’−cgcggatccTCAGGTTCTAACAATAATGTAG−3
’ 
vwb-2c Deletion of vwb (Δvwb) in Jwt and FdltBr strains. 
5’ flanking region. 
5’−GCTCCCAATGATAAAACTAGC−3’ 
vwb-3m Deletion of vwb (Δvwb) in Jwt and FdltBr strains. 
3’ flanking region. 
5’−gctagttttatcattgggagcAAGCAAATAATGAGTTT
GCCG−3’ 
vwb-4cE Deletion of vwb (Δvwb) in Jwt and FdltBr strains. 
3’ flanking region. 
5’−ccggaattcTTTGTTGTCAGCTAAACTTCC−3’ 
vwb-7m Checking the vwb mutants in Jwt and FdltBr strains 
by outside-outside PCR. 3’ flanking region. 
5’−ACCAATTCCAGAGGATTCAG−3’ 
vwb-8c Checking the vwb mutants in Jwt and FdltBr strains 
by outside-outside PCR. 5’ flanking region. 
5’−TATTCAATTTATCTTCAGAAGC−3’ 
vwb-11m Checking the vwb mutants in Jwt and FdltBr strains 
by outside-outside PCR. 3’ flanking region. 
5’−GGCTGAAGATGAGGCTTTG−3’ 
vwb-12c Checking the vwb mutants in Jwt and FdltBr strains 
by outside-outside PCR. 5’ flanking region. 
5’−TAAGTCGCACTTTAATTGC−3’ 
The sequences recognized by the restriction enzymes used in cloning are denoted lower case letters. 
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*Clon KEN-5 recognizes rabbit T-lymphocytes and immunoprecipitates. This antibody recognizes rabbit CD5 but does not bind to rabbit CD5 transfectants. 1037 
Known rabbit CD5 antibodies also show binding to most B-lymphocytes, which are not labeled by this clone (information obtained from datasheet). 1038 
  1039 
Table	4.	The	monoclonal	antibodies	used	in	the	flow	cytometry	studies. 
Monoclonal	antibodies Isotype Specificity Reactivity Clone Reference	&	Company 
Mouse	anti-rabbit	IgM	 IgG1 IgM B-cells NRBM MCA812GA,	AbD	Serotec,	UK 
Mouse	anti-rabbit	T-lymphocytes:	FITC* IgG1 CD5 T-cells KEN-5 MCA800F,	AbD	Serotec,	UK 
Mouse	anti-rabbit	CD4 IgG2a CD4 T	CD4	cells	 KEN-4 MCA799,	AbD	Serotec,	UK 
Mouse	anti-rabbit	CD8 IgG2a CD8 T	CD8	cells	 ISC27A WS0796U-100,	Kingfisher	Biotech,	USA 
Mouse	anti-rabbit	CD25 IgG2b CD25 Activated	T-cells KEI-a1 MCA1119G,	AbD	Serotec,	UK 
Mouse	anti-human	CD14:	FITC IgG2a CD14 Monocytes	and	granulocytes TÜK4 MCA1568F,	AbD	Serotec,	UK 




value  0.5 1 2 3 7 14 21 28 
Epidermis*          
Hyperplasia 100/0/0/0a 100/0/0/0a 30/60/10/0b 27/27/36/10b 0/0/0/100d 0/0/0/100d 0/8/50/42c 0/16/46/38c 0.001 
Reepithelization	
(mitosis) 100/0/0/0
a 100/0/0/0a 100/0/0/0a 100/0/0/0a 100/0/0/0a 58/8/17/17b 25/25/0/50b 0/0/8/92c 
0.001 
Superficial	dermis          
Vascular	dilatation	 80/20/0/0a 30/60/10/0ab 30/60/0/0ab 18/55/27/0bc 0/10/40/50d 0/50/50/00c 17/42/33/8c 23/46/31/0bc 0.001 
Hemorrhages 89/0/0/11a 10/80/10/0bc 40/50/10/0abc 27/27/36/10c 10/40/30/20c 50/25/17/8ab 67/33/0/0a 31/23/38/8c 0.001 
Edema 80/0/20/0ab 70/10/20/0ab 80/0/20/0ab 18/10/36/36d 0/60/20/20cd 33/17/33/17bc 67/25/8/0ab 85/15/0/0a 0.001 
Deep	dermis          
Vascular	dilatation 80/20/0/0a 0/100/0/0a 30/70/0/0a 18/55/27/0ab 0/60/40/0b 0/100/0/0ab 17/42/33/8ab 23/46/23/8a 0.132 
Perivascular	
inflammation 30/50/10/10
b 0/20/10/70e 10/10/30/50de 0/36/55/9c 0/20/60/20cd 0/40/30/30cd 0/66/17/17bc 75/15/8/0a 0.001 
Heterophiles	diffuses 40/50/10/0a 10/40/10/40bc 10/20/50/20bc 0/27/63/0bc 0/30/30/40c 8/33/42/17b 0/41/42/17bc 69/15/16/0a 0.001 
Heterophiles	
organized	(abscess) 80/10/0/10




a 50/30/20/0b 40/10/0/50cd 0/0/18/82d 0/0/50/50cd 20/0/40/40c 75/0/17/8b 92/8/0/0ab 
0.001 
Hemorrhages 100/0/0/0a 40/60/0/0cd 30/70/0/0d 0/100/0/0d 30/70/0/0d 75/17/0/8bc 100/0/0/0a 85/15/0/0b 0.001 
Granulation	tissue 100/0/0/0a 100/0/0/0a 100/0/0/0a 100/0/0/0a 100/0/0/0a 75/8/17/0b 0/9/8/83c 15/0/0/85c 0.001 
Regeneration	(hair	
follicles) 100/0/0/0
a 100/0/0/0a 100/0/0/0a 100/0/0/0a 100/0/0/0a 100/0/0/0a 83/17/0/0a 9/76/15/0b 
0.001 
Cutaneous	muscle          
Interstitial	
inflammation 40/40/0/20
b 10/10/60/20cde 10/50/20/20bcd 0/28/36/36de 0/0/30/70e 0/50/10/40cd 25/33/25/17bc 75/25/0/0a 
0.001 
Atrophy/degeneration 90/0/10/0a 70/20/10/0ab 70/20/10/0ab 35/55/10/0ab 0/30/70/0c 8/50/8/34c 33/42/8/17bc 75/8/0/15a 0.001 
Hypertrophy 100/0/0/0 100/0/0/0 100/0/0/0 100/0/0/0 100/0/0/0 75/25/0/0 92/8/0/0 69/31/0/0 0.204 
Interruption 90/10/0/0a 100/0/0/0a 100/0/0/0a 70/20/10/0ab 40/30/20/10b 50/33/0/17ab 76/8/8/8ab 100/0/0/0a 0.010 








Table 6. Evolution of the concentration (pg/mL) of cytokines on plasma and skin tissue after the intradermal inoculation with the Jwt strain (n = 1041 
10 animals per day). 1042 
 Postinoculation	time	(days) 
SEM P-value 
 0 0.5 1 2 3 7 14 21 28 
Plasma            
IL-4 3.587ab 2.317a 3.375a 5.701b 3.780b 3.751b 3.886b 5.552b 8.904c 0.807 <0.001 
IL-18 126.8ab 316.4bc 263.0bc 245.9b 328.2bc 87.2a 350.0c 307.2bc 463.4d 39.8 <0.001 
Skin            
IL-4 8.998a 6.419a 7.080a 7.780a 9.392a 7.307a 8.774a 9.951a 15.479b 1.554 0.001 
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Table 7. The histopathological findings observed after the inoculation of different S. aureus strains (n = 10 animals per day and strain). 
 
  S. aureus strain P value 
 FdltBr Jwt Jrot+ JdltBh  Strain Time*Strain 
Epidermis*        
Hyperplasia 74/2/21/3b 42/10/13/35c 83/8/6/3a 90/10/0/0a  0.001 0.001 
Reepithelization (mitosis) 100/0/0/0 100/0/0/0 100/0/0/0 100/0/0/0  1.000 1.000 
Superficial dermis        
Vascular dilatation 44/52/4/0b 16/42/26/16c 40/57/3/0a 33/67/0/0ab  0.001 0.001 
Hemorrhages 58/26/16/0a 16/48/26/10b 50/37/13/0a 50/43/7/0a  0.001 0.001 
Edema 23/48/29/0b 29/26/26/19b 40/40/17/3a 50/47/3/0a  0.001 0.005 
Deep dermis         
Vascular dilatation 2/46/52/0b 0/84/13/3a 0/77/13/10a 0/41/56/3b  0.001 0.012 
Perivascular inflammation 2/46/52/0a 0/26/42/32b 77/7/16/0a 3/47/50/0a  0.001 0.001 
Heterophiles diffuses 4/54/34/8ab 0/36/39/25b 0/64/23/13a 0/47/47/6a  0.016 0.060 
Heterophiles organized (abscess) 58/4/2/36b 6/4/3/87c 60/7/3/30a 67/17/13/3a  0.001 0.001 
Eosinophilic peri-abscess layer 75/17/4/4b 16/10/29/45c 83/4/7/6ab 100/0/0/0a  0.001 0.095 
Hemorrhages 100/0/0/0a 23/77/0/0b 100/0/0/0a 100/0/0/0a  0.001 0.845 
Granulation tissue 100/0/0/0 100/0/0/0 100/0/0/0 100/0/0/0  1.000 1.000 
Cutaneous muscle        
Interstitial inflammation 15/46/27/12b 3/14/42/41c 21/63/3/13a 17/53/27/3a  0.001 0.008 
Atrophy/degeneration 71/19/10/0b 35/35/30/0b 86/8/3/3a 100/0/0/0a  0.001 0.029 
Hypertrophy 100/0/0/0 100/0/0/0 97/3/0/0 100/0/0/0  0.415 1.000 
Interruption 96/2/2/0 68/19/10/3 97/0/0/3 97/3/0/0  0.191 0.525 
Fibrosis 100/0/0/0 81/19/0/0 100/0/0/0 100/0/0/0  0.066 0.144 
* Each histological parameter presents 4 values (w/x/y/z) that indicate the average percentage of animals for the three sampling times (1, 3 and 7 days 
postinfection). The microscopic findings are classified as absent (w), mild (x), moderate (y), severe (z). 
For a given trait presented in a row, P-Value tests hypothesis H0: there was no effect of treatment to explain the observed trait variance. 
a-c The means in a same row not sharing letters significantly differ (P<0.05). 
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Supplemental Figure 1. Severe dermonecrosis (A: external aspect; B: sagittal cut of formalin fixed 1 
tissue; C: microscopically low magnification view stained with H&E) characterized by a peripheral halo 2 
of inflammatory cells (arrows) and a center of coagulative necrosis (asterisk) at 3 days postinoculation 3 
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Supplemental Table 1. The statistical models used in this work based on the trait and the study. 
Group of traits Study 1*  Study 2† 
 Trait 1a. Jwt 1b. Mutants  FdltBr vs. J 
 Animal weight M1    
 Body temperature M1   M7 
 CFU M2   M8 
Gross lesions     
 Erythema (area) M3   M9 
 Nodule (volume) M3   M9 
Histological findings     
 Epidermal thickening M5   M10 
 Reepithelization M5   M10 
 Vascular dilatation  M5   M10 
 Perivascular inflammation M5   M10 
 Edema  M5   M10 
 Hemorraghes M5   M10 
 Heterophiles diffuses M5 M6  M10 
 Heterophiles organized (abscess) M5   M10 
 Eosinophilic peri-abscess layer M5 M6  M10 
 Granulation tissue M5   M10 
 Splendore-Hoeppli phenomena  M6   
 Regeneration (mitosis) M5   M10 
 Interstitial inflammation M5 M6  M10 
 Atrophy/degeneration M5 M6  M10 
 Hypertrophy M5   M10 
 Interruption M5   M10 
 Fibrosis M5   M10 
Immunohistochemistry     
 Macrophages M1   M7 
 Plasma cells M1   M7 
 T-lymphocytes M1   M7 
 B-lymphocytes M4   M7 
Hematology and flow cytometry     
 Total leukocytes M1   M7 
 Granulocytes M1   M7 
 Total lymphocytes M1   M7 
 B-lymphocytes M1   M7 
 T-lymphocytes M1   M7 
 T CD4+ M1   M7 
 T CD8+ M1   M7 
 T CD25+ M1   M7 
 Monocytes M1   M7 
Cytokines      
IL-1b M1    
IL-4 M1    
IL-17 M1    
IL-18 M1    
IFN-gamma M1    
* Study 1. Characterization of the model after infection with a Jwt (1a. Jwt) and mutant strains (1b. Mutants: 
JΔcoaΔvwb, JΔhla, JΔpsmα and JΔagr).  
† Study 2. Comparison of lesions caused by a human “rabbitized” strain (FdltBr) with different-virulence rabbit 
strains (J: Jwt, Jrot+ and JdltBh). 
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